JOHNSON & JOHNSON - 25 Nov 2025 Form 4/A - Amendment Insider Report for CVRx, Inc. (CVRX)

Role
10%+ Owner
Signature
Johnson & Johnson By /s/ Marc Larkins, Secretary
Issuer symbol
CVRX
Transactions as of
25 Nov 2025
Net transactions value
-$224,040
Form type
4/A - Amendment
Filing time
08 Jan 2026, 16:05:54 UTC
Date Of Original Report
01 Dec 2025
Previous filing
25 Nov 2025
Next filing
01 Dec 2025
SEC
View on sec.gov

Reporting Owners (2)

Name Relationship Address Signature Signature date CIK
JOHNSON & JOHNSON 10%+ Owner ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK Johnson & Johnson By /s/ Marc Larkins, Secretary 08 Jan 2026 0000200406
Johnson & Johnson Innovation - JJDC, Inc. 10%+ Owner 410 GEORGE STREET, NEW BRUNSWICK Johnson & Johnson Innovation - JJDC, Inc. By: /s/ Jill McManus, Assistant Treasurer 08 Jan 2026 0000924020

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVRX Common Stock Sale $160,480 -16,000 -0.4% $10.03 4,031,198 25 Nov 2025 By Johnson & Johnson Innovation - JJDC, Inc. F1, F2
transaction CVRX Common Stock Sale $63,560 -6,337 -0.16% $10.03 4,024,861 26 Nov 2025 By Johnson & Johnson Innovation - JJDC, Inc. F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.00 to $10.22. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. ("JJDC"). JJDC is a wholly-owned subsidiary of Johnson & Johnson.
F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.00 to $10.23. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

This Amendment to the Form 4 filed on 12/01/2025 is being filed to include the sale of shares on 11/25/2025, which was inadvertently omitted from the original filing due to an administrative oversight.